Tamsulosin and Dementia in old age: is there any relationship?
Tamsulosin is used to treat Benign Prostatic Hyperplasia (BPH), prescribed annually to about 12.6 million patients worldwide. It is an alpha-adrenergic antagonist that reduces the tone of the prostate smooth muscle involved in the pathophysiology of BPH. By acting on alpha 1A receptors, predominant...
Main Author: | Rebecca Renata Lapenda do Monte, Karina de Andrade Vidal Costa, Arnaldo Santiago Nunes Junior, Am lia Cinthia Meneses R go, Irami Ara jo Filho |
---|---|
Format: | Article |
Language: | English |
Published: |
Bulgarian Association of Young Surgeons
2019-10-01
|
Series: | International Journal of Medical Reviews and Case Reports |
Subjects: | |
Online Access: | http://www.mdpub.net/index.php?fulltxt=62889&fulltxtj=172&fulltxtp=172-1566846841.pdf |
Similar Items
-
Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01) -
Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01) -
EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
by: Farhan Khan, et al.
Published: (2021-08-01) -
Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride
by: Hassan El-Tatawy, et al.
Published: (2015-09-01) -
Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial
by: Shin YS, et al.
Published: (2016-09-01)